Halozyme Therapeutics reported $83.69M in EBIT for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
DBV Technologies DBVT:US USD -18020000 5.8M
Acadia Pharmaceuticals ACAD:US USD -30866000 2.78M
Agios Pharmaceuticals AGIO:US USD -91090000 6.55M
Alnylam Pharmaceuticals ALNY:US USD -258040000 66.35M
Amarin AMRN:US USD 1.43M 39.05M
Amgen AMGN:US USD 2.66B 71M
Aptinyx Inc APTX:US USD -14657000 2.45M
Baxter International BAX:US USD 521M 89M
Cara Therapeutics CARA:US USD -23845000 19.37M
Cytokinetics CYTK:US USD -108441000 97.57M
Eli Lilly And LLY:US USD 1.95B 294.9M
Esperion Therapeutics ESPR:US USD -41623000 10.75M
Halozyme Therapeutics HALO:US USD 83.69M 49.63M
Immunogen IMGN:US USD -77429000 16.38M
Intercept Pharmaceuticals ICPT:US USD -10144000 3.22M
Intra Cellular Therapies ITCI:US USD -55629000 32.29M
Intrexon XON:US USD -7614000 15.91M
IONIS PHARMACEUT IONS:US USD -59154000 26.36M
JAZZ PHA JAZZ:US USD 199.21M 72.86M
Mannkind MNKD:US USD -11409000 13.55M
Minerva Neurosciences NERV:US USD -5207150 1.76M
Nektar Therapeutics NKTR:US USD -37471000 10.24M
Peregrine Pharmaceuticals PPHM:US USD 2.74M 1.67M
Pfizer PFE:US USD 9.7B 2.43B
United Therapeutics UTHR:US USD 314.3M 112.5M